B. Braun controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2022
Continued Russian operations after the invasion of Ukraine
B. Braun has faced criticism for maintaining business activities in Russia after the invasion of Ukraine. The Leave Russia project reported Russian subsidiary revenue and employment figures for 2021 and characterized the company as continuing operations rather than exiting the market.
2010
US Medicaid overbilling settlement
B. Braun Medical agreed to pay $14.7 million to resolve allegations that the US Medicaid program had paid inflated amounts for dozens of products. The settlement involved a B. Braun subsidiary and concerned government healthcare reimbursement.
1969
Lyodura and Creutzfeldt–Jakob disease transmission
Lyodura, a dura-mater graft used in neurosurgery, was linked to transmission of Creutzfeldt–Jakob disease. Accounts cited in the reference material report inadequate donor histories, including tissue allegedly obtained through black-market cadavers, and associate at least 154 diagnosed cases with the product. In 2002, B. Braun agreed with Japanese health authorities to compensate affected families.